LGND ์ต์ ๋ถ๊ธฐ ์์ต
๋ฐํ ๋ ์ง10/29/2026
EPS ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)-1.43
์์ต ์ค์ (๋ฏธ๊ตญ ๋ฌ๋ฌ)149.03M
Ligand Pharmaceuticals Inc ์ค์ ๋ฐํ ๋ ์ง ๋ฐ ๋ณด๊ณ ์
์ด ํ์ด์ง๋ ์ต์ Ligand Pharmaceuticals Inc ์์ต ๋ณด๊ณ ์, ๋ค๊ฐ์ค๋ Ligand Pharmaceuticals Inc ์ค์ ๋ฐํ ๋ ์ง, ๊ณผ๊ฑฐ ๋ฐ์ดํฐ ๋ฐ Ligand Pharmaceuticals Inc ์ค์ ๋ฐํ ์ปจํผ๋ฐ์ค ๋ด์ค๋ฅผ ํฌํจํ ์์ธํ Ligand Pharmaceuticals Inc ์์ต ๋ฐ์ดํฐ๋ฅผ ์ ๊ณตํฉ๋๋ค.
LGND ํฅํ ๋ถ๊ธฐ ์ค์
๋ฐํ ๋ ์ง--
EPS ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
์์ต ์์(๋ฏธ๊ตญ ๋ฌ๋ฌ)--
LGND FY2025 ์์ต
์ฐ๊ฐ ์ฃผ๋น์์ด์ต ์ฑ์ฅ๋ฅ (YoY)6.132881.81%
์ฐ๊ฐ ๋งค์ถ ์ฑ์ฅ๋ฅ (YoY)215.01M28.65%
Ligand Pharmaceuticals Inc(LGND) ์ค์ ๋ด์ญ
| ๋ฐํ์ผ | ๊ธฐ๊ฐ ์ข ๋ฃ | EPS/์์ | ์์ต/์์ | EPS ์ํ๋ผ์ด์ฆ % | ์์ต ์ํ๋ผ์ด์ฆ % |
|---|---|---|---|---|---|
| 10/29/2026 | 09/2026 | -1.43/2.38 | 149.03M/77.23M | -159.92% | 92.96% |
| 8/6/2026 | 06/2026 | 2.42/1.82 | 63.69M/60.76M | 32.50% | 4.82% |
| 5/7/2026 | 03/2026 | -0.67/1.82 | 51.72M/58.70M | -136.97% | -11.88% |
| 2/26/2026 | 12/2025 | 2.21/1.56 | 59.67M/55.59M | 41.33% | 7.33% |
| 11/6/2025 | 09/2025 | 5.99/1.93 | 115.46M/58.79M | 211.06% | 96.38% |
| 8/7/2025 | 06/2025 | 0.25/1.42 | 47.63M/43.87M | -82.36% | 8.56% |
| 5/8/2025 | 03/2025 | -2.21/1.21 | 45.33M/38.70M | -282.56% | 17.13% |
| 2/27/2025 | 12/2024 | -1.64/1.19 | 42.81M/39.02M | -237.66% | 9.71% |
Ligand Pharmaceuticals Inc ์ต์ ์ค์ ๋ฐํ ์ ํ ํ์ ๊ธฐ๋ก๎
๋ฆฌ๊ฐ๋(LGND) 2026๋ 3๋ถ๊ธฐ ์ค์ ๋ฐํํ: ๋ก์ดํฐ ๋งค์ถ 51% ์ฆ๊ฐ, EPS ๊ฐ์ด๋์ค ์ํฅ
๋ผ์ด๊ฐ๋์ 2026๋
3๋ถ๊ธฐ ์ค์ ๋ฐํ ์ฝํผ๋ฐ์ค ์ฝ์์๋ 51%์ ๋ก์ดํฐ ๋งค์ถ ์ฑ์ฅ, ํ์คํ๋ฆฌ ๋ชจ๋ฉํ
, XOMA ํฌํธํด๋ฆฌ์ค ๋ฐ ์กฐ์ EPS ๊ฐ์ด๋์ค ์ํฅ์ด ๋ค๋ค์ก๋ค.